Clinical efficacy and safety of bispecific antibodies for the treatment of solid tumors: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Clinical efficacy and safety of bispecific antibodies for the treatment of solid tumors: a systematic review and meta-analysis

Author:

Nejadghaderi Seyed Aria¹²³,Balibegloo Maryam¹²⁴,Noori Maryam⁵⁶,Fayyaz Farimah²⁴⁷,Saghazadeh Amene¹⁸,Rezaei Nima⁴⁸⁹

Affiliation:

1. Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran

2. Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran

3. School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

4. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran

5. Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

6. Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran

7. Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran

8. Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran

9. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Funder

no funding

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

Reference45 articles.